Table 4

Meta-analysis results for all tendinopathy locations pooled across different outcome domains

Outcome domainSmall
(95%CrI)		Medium
(95%CrI)		Large
(95%CrI)		Study VPC
(75%CrI)		Outcome VPC
(75%CrI)		Measurement VPC
(75%CrI)
Function0.62
(0.45 to 0.77)		1.05
(0.88 to 1.23)		1.78
(1.53 to 2.09)		0.43
(0.03 to 0.81)		0.55
(0.17 to 0.94)		0.01
(0.00 to 0.04)
Disability0.61
(0.55 to 0.68)		1.04
(0.98 to 1.11)		1.51
(1.43 to 1.60)		0.78
(0.68 to 0.88)		0.15
(0.08 to 0.24)		0.05
(0.00 to 0.13)
Pain0.53
(0.45 to 0.61)		0.94
(0.87 to 1.02)		1.45
(1.32 to 1.58)		0.26
(0.06 to 0.46)		0.71
(0.51 to 0.90)		0.02
(0.00 to 0.07)
ROM0.21
(0.14 to 0.27)		0.42
(0.36 to 0.48)		0.65
(0.58 to 0.73)		0.86
(0.76 to 0.93)		0.11
(0.05 to 0.20)		0.01
(0.00 to 0.06)
PFC0.16
(0.11 to 0.21)		0.38
(0.34 to 0.43)		0.64
(0.59 to 0.71)		0.73
(0.61 to 0.82)		0.27
(0.18 to 0.38)		0.01
(0.00 to 0.02)
QoL−0.21
(−0.32 to −0.09)		0.25
(0.12 to 0.38)		0.68
(0.48 to 0.93)		0.84
(0.65 to 0.93)		0.14
(0.05 to 0.33)		0.01
(0.00 to 0.04)

  • Small: 0.25 quantile; medium: 0.5 quantile; large: 0.75 quantile.

  • CrI, credible interval; PFC, physical function capacity; QoL, quality of life; ROM, range of motion; VPC, variance partition coefficient.